79174726 - PURYTRA FARMACEUTICI

Information

  • Trademark
  • 79174726
  • Serial Number
    79174726
  • Registration Number
    5038453
  • Filing Date
    April 08, 2015
    9 years ago
  • Registration Date
    September 13, 2016
    8 years ago
  • Transaction Date
    January 07, 2024
    11 months ago
  • Status Date
    March 24, 2023
    a year ago
  • Published for Opposition Date
    June 28, 2016
    8 years ago
  • Location Date
    September 13, 2016
    8 years ago
  • Status Code
    709
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    NGUYEN, NICOLE A
  • Attorney Name
    Alex Patel
    Law Office Assigned Location Code
    L70
  • Owners
Mark Drawing Code
3000
Mark Identification
PURYTRA FARMACEUTICI
Case File Statements
  • DM0000: The mark consists of the wording "PURYTRA" and "FARMACEUTICI"; the word "PURYTRA" is in capital letters and light green colour, with the letter "Y" stretched and curved in colour light blue, with a dark green and light green leaf between the arms of the "Y" forming the head of a human-like figure. The word "FARMACEUTICI" is below the word "PURYTRA", in capital letters and light blue colour; the colors black, white, and/or gray represent background, outlining, shading and/or transparent areas and are not part of the mark.
  • GS0051: Vitamin supplements; dietary and nutritional supplements; nutritional supplements for medical use; dietary supplements and dietetic preparations, namely dietetic foods, namely, crackers and pasta adapted for medical use, dietetic sugar substitutes for medical use; nutraceuticals for use as a dietary supplement; herbal dietary supplements for persons special dietary requirements; pharmaceutical creams, namely, antibiotic creams, hydrocortisone creams, topical analgesic creams; homeopathic pharmaceuticals for use in the treatment of disorders of the nervous system, disorders of the immune system, disorders of the cardio-vascular system, disorders of the metabolic system, disorders of the digestive system, disorders of the respiratory system, disorders of the musculo-skeletal system, disorders of the genitourinary system, inflammatory disorders, dermatology disorders, oncology disorders, hematology disorders, neurology disorders, tissue and organ transplantation disorders, ophthalmology disorders, and gastroenterological disorders; antibacterial pharmaceuticals; diuretic pharmaceutical preparations; medicated moisturising creams for treating dermatological conditions; pharmaceutical preparations for use in dermatology; chemical preparations for pharmaceutical or medical purposes, namely, for disorders of the nervous system, disorders of the immune system, disorders of the cardio-vascular system, disorders of the metabolic system, disorders of the digestive system, disorders of the respiratory system, disorders of the musculo-skeletal system, disorders of the genitourinary system, inflammatory disorders, dermatology disorders, oncology disorders, hematology disorders, neurology disorders, tissue and organ transplantation disorders, ophthalmology disorders, and gastroenterological disorders; medicated skin lotions; acne creams in the nature of face creams containing benzoyl peroxide for medical purposes, namely, the treatment of acne; tissue-regenerative pharmaceutical preparations, namely medicated skin cream for tissue regeneration; pharmaceutical preparations for skin care; medicinal herb extracts; medicinal oils; herbal medicine, namely herbal supplements, for disorders of the nervous system, disorders of the immune system, disorders of the cardio-vascular system, disorders of the metabolic system, disorders of the digestive system, disorders of the respiratory system, disorders of the musculo-skeletal system, disorders of the genitourinary system, inflammatory disorders, dermatology disorders, oncology disorders, hematology disorders, neurology disorders, tissue and organ transplantation disorders, ophthalmology disorders, and gastroenterological disorders; medicinal skin care creams for medical use; antibiotics; antibiotic dermatological products in the nature of antibiotic creams; analgesics
  • GS0031: Cosmetics; skin moisturising gels; cosmetic preparations for skin care; cosmetics in the form of creams; cosmetics in the form of powders, namely bath powder, face powder, make up powder; lotions for cosmetic purposes; facial moisturisers; facial cleansers; skin masks; facial toners, namely, skin toners; facial washes; hair care preparations and non-medicated hair treatment preparations for cosmetic purposes; hair lotions; cosmetic preparations for the use on the hair; body cleaning and beauty care preparations, namely skin cleansing lotions, body creams, deodorants, body scrubs; non-medicated body creams; moisturising body lotions
  • CC0000: The color(s) light green, dark green and light blue is/are claimed as a feature of the mark.
  • GS0011: Raw chemical materials for the formulation of cosmetic products; chemical preparations in the nature of chemical additives for use in the manufacture of cosmetics; emulsifiers for use in the manufacture of cosmetics; botanical extracts for use in making cosmetics; chemical substances, namely scented oils, for use in the manufacture of scented cosmetics; chemical compositions and materials in the nature of chemical thickeners for use in the manufacture of cosmetics; chemical additives for use in the manufacture of pharmaceuticals; preservatives for pharmaceutical preparations; chemicals for use in industry and science; chemical compositions and materials in the nature of chemical additives, chemicals preservatives and emollients for use in the manufacture of cosmetics
  • TR0010: The English translation of the word "FARMACEUTICI" in the mark is "PHARMACEUTICALS".
  • D10000: "FARMACEUTICI"
  • GS0421: Scientific research; industrial research, namely, research in the field of cosmetics, chemistry, pharmacology, biotechnology; research on the subject of pharmaceuticals; biological research; biotechnology research; cosmetics research; biological research and medical research; clinical research, namely, conducting clinical trials for others; research in the field of new cosmetic products; research in the field of new medical products; research in the field of new pharmacological products; research in the field of new dermatological products; scientific research consulting in the field of cosmetics; scientific research services for others in the field of cosmetics, chemistry, pharmacology, biotechnology; scientific research and development services; chemical research; medical and pharmacological research services; scientific laboratory services and scientific research; laboratory research services relating to dermatology
Case File Event Statements
  • 1/7/2024 - 11 months ago
    38 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT
  • 12/18/2023 - a year ago
    37 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS
  • 12/18/2023 - a year ago
    36 - INVALIDATION PROCESSED Type: INPC
  • 11/24/2023 - a year ago
    35 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR
  • 3/24/2023 - a year ago
    34 - CANCELLED SECTION 71 Type: C71T
  • 12/24/2021 - 2 years ago
    33 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 9/13/2021 - 3 years ago
    32 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 1/6/2017 - 7 years ago
    31 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 12/15/2016 - 8 years ago
    30 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 12/15/2016 - 8 years ago
    29 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 12/13/2016 - 8 years ago
    28 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 9/16/2016 - 8 years ago
    27 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 9/13/2016 - 8 years ago
    26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/28/2016 - 8 years ago
    25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/28/2016 - 8 years ago
    24 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/8/2016 - 8 years ago
    23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 6/8/2016 - 8 years ago
    22 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 6/8/2016 - 8 years ago
    21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/17/2016 - 8 years ago
    20 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR
  • 4/29/2016 - 8 years ago
    19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/28/2016 - 8 years ago
    18 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/28/2016 - 8 years ago
    17 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/28/2016 - 8 years ago
    16 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/28/2016 - 8 years ago
    15 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/27/2016 - 8 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/26/2016 - 8 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/26/2016 - 8 years ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/10/2016 - 8 years ago
    11 - CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED Type: CORR
  • 1/15/2016 - 8 years ago
    10 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV
  • 11/21/2015 - 9 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 10/30/2015 - 9 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 10/30/2015 - 9 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 10/30/2015 - 9 years ago
    6 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 10/28/2015 - 9 years ago
    5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 10/27/2015 - 9 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/26/2015 - 9 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/26/2015 - 9 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 10/22/2015 - 9 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR